AIDS 2018

Each year, more than 15,000 global health professionals, advocates, and policymakers come together for the International AIDS Conference to connect and inform the future of AIDS and HIV prevention, management, and cure through the lens of innovation, science, and advocacy. Follow our coverage to learn what the world’s largest global health gathering mean for our industry’s professionals.

Jhpgmup3zmn cz2nfya ns ocyloa1zx1n0qy s4aupkrxlqn01kzpnly9jdjqbpbmztnzbp4eigebearxl0hi cscityolgivuczrtyjbggz90pnch2h4aoblgr7ijwsqxf6rpp

What happened to PEPFAR's $100M Key Population Investment Fund?

DevexAIDS 2018 told the story of a global health crisis

Underlying conversations at the 22nd International AIDS Conference last week was a growing realization that the fight against HIV/AIDS is in crisis, with 1.8 million new infections in 2017, spikes in key populations, and falling funding. Devex rounds up the key takeaways about the biggest concerns, and what can be done.


DevexGlobal Disability Summit, AIDS 2018 conference, and ADB's 2030 strategic plan: This week in development

Officials gather in London for the first-ever summit aimed at making aid more disability-inclusive, the 22nd International AIDS Conference sounds the alarm on remaining challenges in tackling HIV/AIDS, and Ebola outbreak ends.


DevexLaunch of $1.2B coalition to expand HIV services for men

Around the world, men are less likely to receive diagnoses and treatments for HIV/AIDS than women and are more likely to die from the disease. A new partnership of major donors, NGOs, and pharmaceuticals aims to overcome the barriers that prevent men from accessing help.


DevexUNAIDS chief confronted by anti-harassment protestors on stage in Amsterdam

Campaigners hijacked the opening of the 22nd International AIDS Conference to protest the presence of UNAIDS Executive Director Michel Sidibé, who has been criticized for his response to a sexual harassment scandal.


DevexOpinion: The global HIV response is neglecting people who use drugs

People who inject drugs are more than 20 times more likely to contract the virus than the general public — they are also one of the most marginalized groups. Naomi Burke-Shyne, deputy director of Harm Reduction International, explains.


DevexQ&A: Diagnostic tools as the answer to HIV and AIDS

At this week’s International AIDS Conference in Amsterdam, global health care company Abbott rolls out a new point-of-care diagnostic test for HIV and AIDS designed to work in remote and under-resourced settings. The organization's Dr. Kuku Appiah tells Devex how this has the potential to accelerate treatment, prevent transmission, monitor the emergence of drug resistance, and overall, contribute to the UNAIDS 90-90-90 goals.


DevexChristians and the new age of AIDS

Christian evangelicals played a pivotal role in building support for the historic $15 billion investment in fighting HIV and AIDS around the world. U.S. global health leaders are looking to the church again as the fight against the disease enters a new and complex phase.


DevexOpinion: We need to break down barriers for adolescent girls living with HIV. Here's how.

Adolescent girls with HIV face unique and significant barriers to reaching their full potential. Two ICRW experts explain why girls should be a focus at this year's AIDS 2018 conference.


DevexThe 'end of AIDS' is not even nearly in sight, experts warn

Leading experts warn against complacency in the fight against HIV and AIDS, as new data published ahead of the 22nd International AIDS Conference next week shows minimal progress.


DevexUncertainty over PEPFAR support prompts concerns from HIV advocates in Nigeria

PEPFAR's new strategy identifies 13 countries where it will accelerate efforts to achieve epidemic control. Nigeria, despite accounting for 9 percent of the global HIV burden, was not among them.


DevexQ&A: Chip Lyons on PEPFAR's 'great leap into the unknown' of controlling HIV and AIDS

On PEPFAR's 15th anniversary, Devex spoke to Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, about how the initiative has transformed U.S. global health, and where it goes from here.


DevexQ&A: How Rwanda focused PEPFAR funds on 'people-centric, not disease-centric' care

As PEPFAR marks its 15th anniversary, Devex spoke to Agnes Binagwaho about the program, its impacts in Rwanda, and what’s needed both in the fight against HIV and AIDS and to improve health systems.


Devex15 years later, PEPFAR is still at war with a global epidemic

On May 27, 2003, U.S. Congress authorized the largest-ever investment in a single disease in U.S. global health history. Fifteen years later, PEPFAR has saved millions of lives and transformed global development. But to end an epidemic, the flagship HIV/AIDS program will have to go even further — and advocates fear budget pressure could jeopardize the fight.


DevexPEPFAR chief questions US approach to supply chain technical assistance

Speaking at a congressional hearing on USAID's $9.5 billion global health supply chain project, U.S. Ambassador Deborah Birx raised questions about how effectively the $3 billion spent on technical assistance since 2009 has been deployed.


DevexWorld at risk of losing control of HIV and AIDS epidemic, PEPFAR architect says

The HIV and AIDS epidemic could become uncontained if current funding trends continue, warned one of the founding architects of the United States President’s Emergency Plan for AIDS Relief.


DevexGlobal Fund pushes countries to spend faster — or lose funds

For the first time, the Global Fund to Fight AIDS, Tuberculosis and Malaria placed a firm deadline at the end of last December, preventing countries with unspent funds from using them in the new year. The moves aims to increase predictability of spending and enhance the impact of the fund's work, Cynthia Mwase, head of the Africa and Middle East grant management directorate for the fund, told Devex.


DevexEarly HIV diagnosis in infants works in Africa, but the technology must spread to save lives

Diagnostic technology that allows caregivers to know the HIV status of an infant born to an HIV-positive mother in the same day has been introduced across nine sub-Saharan African countries. Early evidence shows success in putting infants on vital drugs, but adoption of this technology remains low, mostly due to a lack of political and donor support, some experts argue.


DevexIn India, one group uses arranged marriages as a way to combat HIV

​Awareness-raising activities, pre-exposure prophylaxis, sexual education — these are all well-known prevention methods when it comes to HIV. But should the global development community be considering marriage matchmaking as another? Devex reports.


Powered by

#AIDS2018

Jobs

See more jobs